schliessen

Filtern

 

Bibliotheken

A novel application of maleimide for advanced drug delivery: in vitro and in vivo evaluation of maleimide-modified pH-sensitive liposomes

Maleimide is a stable and easy-to-handle moiety that rapidly and covalently conjugates thiol groups of cysteine residues in proteins or peptides. Herein, we use maleimide to modify the surface of liposomes in order to obtain an advanced drug delivery system. Employing a small amount (0.3 mol%) of ma... Full description

Journal Title: International Journal of Nanomedicine 2013, Vol.8(1), pp.3855-3866
Main Author: Li, Tianshu
Other Authors: Takeoka, Shinji
Format: Electronic Article Electronic Article
Language: English
Subjects:
ID: ISSN: 1176-9114 ; E-ISSN: 1178-2013 ; DOI: 10.2147/IJN.S47749
Zum Text:
SendSend as email Add to Book BagAdd to Book Bag
Staff View
recordid: proquest2223933388
title: A novel application of maleimide for advanced drug delivery: in vitro and in vivo evaluation of maleimide-modified pH-sensitive liposomes
format: Article
creator:
  • Li, Tianshu
  • Takeoka, Shinji
subjects:
  • Drug Delivery Systems
  • Polyethylene Glycol
  • Maleimide
  • Liposome
  • Thiol-Reactive
  • Ph Responsive
  • Drug Delivery System
ispartof: International Journal of Nanomedicine, 2013, Vol.8(1), pp.3855-3866
description: Maleimide is a stable and easy-to-handle moiety that rapidly and covalently conjugates thiol groups of cysteine residues in proteins or peptides. Herein, we use maleimide to modify the surface of liposomes in order to obtain an advanced drug delivery system. Employing a small amount (0.3 mol%) of maleimide-polyethylene glycol (PEG) to modify the surface of the liposomes M-GGLG-liposomes, composed of 1,5-dihexadecyl N,N-diglutamyl-lysyl-L-glutamate (GGLG)/cholesterol/poly(ethylene glycol) 1,2-distearoyl-sn-glycero-3-phosphoethanolamine (PEG5000-DSPE)/maleimide-PEG5000-Glu2C18 at a molar ratio of 5:5:0.03:0.03, drug delivery efficiency was remarkably improved both in vitro and in vivo compared to unmodified liposomes (GGLG-liposomes, composed of GGLG/cholesterol/PEG5000-DSPE/PEG5000-Glu2C18 at a molar ratio of 5:5:0.03:0.03). Moreover, this modification did not elicit any detectable increase in cytotoxicity. The maleimide-modification did not alter the physical characteristics of the liposomes such as size, zeta potential, pH sensitivity, dispersibility and drug encapsulation efficiency. However, M-GGLG-liposomes were more rapidly (≥2-fold) internalized into HeLa, HCC1954, and MDA-MB-468 cells compared to GGLG-liposomes. In vivo, M-GGLG-liposomes encapsulating doxorubicin (M-GGLG-DOX-liposomes) also showed a more potent antitumor effect than GGLG-DOX-liposomes and the widely used 1,2-dipalmitoyl-sn-glycero-3-phosphocholine (DPPC)-DOX-liposomes after two subcutaneous injections around breast cancer tissue in mice. The biodistribution of liposomes in this model was observed using an in vivo imaging system, which showed that M-GGLG-liposomes were present for significantly longer at the injection site compared to GGLG-liposomes. The outstanding biological functions of the maleimide-modified liposomes as a novel drug delivery system make them ideally suited to a wide range of applications.
language: eng
source:
identifier: ISSN: 1176-9114 ; E-ISSN: 1178-2013 ; DOI: 10.2147/IJN.S47749
fulltext: fulltext_linktorsrc
issn:
  • 11769114
  • 1176-9114
  • 11782013
  • 1178-2013
url: Link


@attributes
ID1480565322
RANK0.07
NO1
SEARCH_ENGINEprimo_central_multiple_fe
SEARCH_ENGINE_TYPEPrimo Central Search Engine
LOCALfalse
PrimoNMBib
record
control
sourcerecordid2223933388
sourceidproquest
recordidTN_proquest2223933388
sourcesystemOther
pqid2223933388
galeid374920697
display
typearticle
titleA novel application of maleimide for advanced drug delivery: in vitro and in vivo evaluation of maleimide-modified pH-sensitive liposomes
creatorLi, Tianshu ; Takeoka, Shinji
ispartofInternational Journal of Nanomedicine, 2013, Vol.8(1), pp.3855-3866
identifier
subjectDrug Delivery Systems ; Polyethylene Glycol ; Maleimide ; Liposome ; Thiol-Reactive ; Ph Responsive ; Drug Delivery System
descriptionMaleimide is a stable and easy-to-handle moiety that rapidly and covalently conjugates thiol groups of cysteine residues in proteins or peptides. Herein, we use maleimide to modify the surface of liposomes in order to obtain an advanced drug delivery system. Employing a small amount (0.3 mol%) of maleimide-polyethylene glycol (PEG) to modify the surface of the liposomes M-GGLG-liposomes, composed of 1,5-dihexadecyl N,N-diglutamyl-lysyl-L-glutamate (GGLG)/cholesterol/poly(ethylene glycol) 1,2-distearoyl-sn-glycero-3-phosphoethanolamine (PEG5000-DSPE)/maleimide-PEG5000-Glu2C18 at a molar ratio of 5:5:0.03:0.03, drug delivery efficiency was remarkably improved both in vitro and in vivo compared to unmodified liposomes (GGLG-liposomes, composed of GGLG/cholesterol/PEG5000-DSPE/PEG5000-Glu2C18 at a molar ratio of 5:5:0.03:0.03). Moreover, this modification did not elicit any detectable increase in cytotoxicity. The maleimide-modification did not alter the physical characteristics of the liposomes such as size, zeta potential, pH sensitivity, dispersibility and drug encapsulation efficiency. However, M-GGLG-liposomes were more rapidly (≥2-fold) internalized into HeLa, HCC1954, and MDA-MB-468 cells compared to GGLG-liposomes. In vivo, M-GGLG-liposomes encapsulating doxorubicin (M-GGLG-DOX-liposomes) also showed a more potent antitumor effect than GGLG-DOX-liposomes and the widely used 1,2-dipalmitoyl-sn-glycero-3-phosphocholine (DPPC)-DOX-liposomes after two subcutaneous injections around breast cancer tissue in mice. The biodistribution of liposomes in this model was observed using an in vivo imaging system, which showed that M-GGLG-liposomes were present for significantly longer at the injection site compared to GGLG-liposomes. The outstanding biological functions of the maleimide-modified liposomes as a novel drug delivery system make them ideally suited to a wide range of applications.
languageeng
source
version7
oafree_for_read
lds50peer_reviewed
links
openurl$$Topenurl_article
openurlfulltext$$Topenurlfull_article
linktorsrc$$Uhttp://search.proquest.com/docview/2223933388/?pq-origsite=primo$$EView_record_in_ProQuest_(subscribers_only)
search
creatorcontrib
0Li, Tianshu
1Takeoka, Shinji
titleA novel application of maleimide for advanced drug delivery: in vitro and in vivo evaluation of maleimide-modified pH-sensitive liposomes
descriptionMaleimide is a stable and easy-to-handle moiety that rapidly and covalently conjugates thiol groups of cysteine residues in proteins or peptides. Herein, we use maleimide to modify the surface of liposomes in order to obtain an advanced drug delivery system. Employing a small amount (0.3 mol%) of maleimide-polyethylene glycol (PEG) to modify the surface of the liposomes M-GGLG-liposomes, composed of 1,5-dihexadecyl N,N-diglutamyl-lysyl-L-glutamate (GGLG)/cholesterol/poly(ethylene glycol) 1,2-distearoyl-sn-glycero-3-phosphoethanolamine (PEG5000-DSPE)/maleimide-PEG5000-Glu2C18 at a molar ratio of 5:5:0.03:0.03, drug delivery efficiency was remarkably improved both in vitro and in vivo compared to unmodified liposomes (GGLG-liposomes, composed of GGLG/cholesterol/PEG5000-DSPE/PEG5000-Glu2C18 at a molar ratio of 5:5:0.03:0.03). Moreover, this modification did not elicit any detectable increase in cytotoxicity. The maleimide-modification did not alter the physical characteristics of the liposomes such as size, zeta potential, pH sensitivity, dispersibility and drug encapsulation efficiency. However, M-GGLG-liposomes were more rapidly (≥2-fold) internalized into HeLa, HCC1954, and MDA-MB-468 cells compared to GGLG-liposomes. In vivo, M-GGLG-liposomes encapsulating doxorubicin (M-GGLG-DOX-liposomes) also showed a more potent antitumor effect than GGLG-DOX-liposomes and the widely used 1,2-dipalmitoyl-sn-glycero-3-phosphocholine (DPPC)-DOX-liposomes after two subcutaneous injections around breast cancer tissue in mice. The biodistribution of liposomes in this model was observed using an in vivo imaging system, which showed that M-GGLG-liposomes were present for significantly longer at the injection site compared to GGLG-liposomes. The outstanding biological functions of the maleimide-modified liposomes as a novel drug delivery system make them ideally suited to a wide range of applications.
subject
0Drug Delivery Systems
1Polyethylene Glycol
2Maleimide
3Liposome
4Thiol-Reactive
5Ph Responsive
6Drug Delivery System
7maleimide
8liposome
9thiol-reactive
10pH responsive
11drug delivery system
general
0English
1Taylor & Francis Ltd.
210.2147/IJN.S47749
3Health & Medical Collection (Alumni edition)
4Health & Medical Collection
5Publicly Available Content Database
6ProQuest Research Library
7ProQuest Central
8ProQuest Hospital Collection
9Research Library (Alumni edition)
10Hospital Premium Collection (Alumni edition)
11ProQuest Health & Medical Complete
12ProQuest Central (new)
13ProQuest Central K-12
14ProQuest Central Korea
15Research Library Prep
16Health Research Premium Collection
17Health Research Premium Collection (Alumni edition)
18ProQuest Central Essentials
19ProQuest One Academic
sourceidproquest
recordidproquest2223933388
issn
011769114
11176-9114
211782013
31178-2013
rsrctypearticle
creationdate2013
addtitleInternational Journal of Nanomedicine
searchscope
01006759
11006761
21006993
31007067
41007899
51008005
61008875
71008886
81009127
91009240
1010000025
1110000034
1210000039
1310000047
1410000064
1510000118
1610000119
1710000155
1810000156
1910000164
2010000255
2110000256
2210000257
2310000258
2410000259
2510000270
2610000271
2710000281
2810000348
2910000360
30proquest
scope
01006759
11006761
21006993
31007067
41007899
51008005
61008875
71008886
81009127
91009240
1010000025
1110000034
1210000039
1310000047
1410000064
1510000118
1610000119
1710000155
1810000156
1910000164
2010000255
2110000256
2210000257
2310000258
2410000259
2510000270
2610000271
2710000281
2810000348
2910000360
30proquest
lsr43
01006759true
11006761true
21006993true
31007067true
41007899true
51008005true
61008875true
71008886true
81009127true
91009240true
1010000025true
1110000034true
1210000039true
1310000047true
1410000064true
1510000118true
1610000119true
1710000155true
1810000156true
1910000164true
2010000255true
2110000256true
2210000257true
2310000258true
2410000259true
2510000270true
2610000271true
2710000281true
2810000348true
2910000360true
startdate20130101
enddate20130101
citationpf 3855 pt 3866 vol 8 issue 1
lsr30VSR-Enriched:[pqid, galeid]
sort
titleA novel application of maleimide for advanced drug delivery: in vitro and in vivo evaluation of maleimide-modified pH-sensitive liposomes
authorLi, Tianshu ; Takeoka, Shinji
creationdate20130101
lso0120130101
facets
frbrgroupid7349176802692036978
frbrtype5
newrecords20190515
languageeng
creationdate2013
topic
0Drug Delivery Systems
1Polyethylene Glycol
2Maleimide
3Liposome
4Thiol-Reactive
5Ph Responsive
6Drug Delivery System
collection
0Health & Medical Collection (Alumni edition)
1Health & Medical Collection
2Publicly Available Content Database
3ProQuest Research Library
4ProQuest Central
5ProQuest Hospital Collection
6Research Library (Alumni edition)
7Hospital Premium Collection (Alumni edition)
8ProQuest Health & Medical Complete
9ProQuest Central (new)
10ProQuest Central K-12
11ProQuest Central Korea
12Research Library Prep
13Health Research Premium Collection
14Health Research Premium Collection (Alumni edition)
15ProQuest Central Essentials
16ProQuest One Academic
prefilterarticles
rsrctypearticles
creatorcontrib
0Li, Tianshu
1Takeoka, Shinji
jtitleInternational Journal of Nanomedicine
toplevelpeer_reviewed
delivery
delcategoryRemote Search Resource
fulltextfulltext_linktorsrc
addata
aulast
0Li
1Takeoka
aufirst
0Tianshu
1Shinji
au
0Li, Tianshu
1Takeoka, Shinji
atitleA novel application of maleimide for advanced drug delivery: in vitro and in vivo evaluation of maleimide-modified pH-sensitive liposomes
jtitleInternational Journal of Nanomedicine
risdate20130101
volume8
issue1
spage3855
epage3866
pages3855-3866
issn1176-9114
eissn1178-2013
formatjournal
genrearticle
ristypeJOUR
abstractMaleimide is a stable and easy-to-handle moiety that rapidly and covalently conjugates thiol groups of cysteine residues in proteins or peptides. Herein, we use maleimide to modify the surface of liposomes in order to obtain an advanced drug delivery system. Employing a small amount (0.3 mol%) of maleimide-polyethylene glycol (PEG) to modify the surface of the liposomes M-GGLG-liposomes, composed of 1,5-dihexadecyl N,N-diglutamyl-lysyl-L-glutamate (GGLG)/cholesterol/poly(ethylene glycol) 1,2-distearoyl-sn-glycero-3-phosphoethanolamine (PEG5000-DSPE)/maleimide-PEG5000-Glu2C18 at a molar ratio of 5:5:0.03:0.03, drug delivery efficiency was remarkably improved both in vitro and in vivo compared to unmodified liposomes (GGLG-liposomes, composed of GGLG/cholesterol/PEG5000-DSPE/PEG5000-Glu2C18 at a molar ratio of 5:5:0.03:0.03). Moreover, this modification did not elicit any detectable increase in cytotoxicity. The maleimide-modification did not alter the physical characteristics of the liposomes such as size, zeta potential, pH sensitivity, dispersibility and drug encapsulation efficiency. However, M-GGLG-liposomes were more rapidly (≥2-fold) internalized into HeLa, HCC1954, and MDA-MB-468 cells compared to GGLG-liposomes. In vivo, M-GGLG-liposomes encapsulating doxorubicin (M-GGLG-DOX-liposomes) also showed a more potent antitumor effect than GGLG-DOX-liposomes and the widely used 1,2-dipalmitoyl-sn-glycero-3-phosphocholine (DPPC)-DOX-liposomes after two subcutaneous injections around breast cancer tissue in mice. The biodistribution of liposomes in this model was observed using an in vivo imaging system, which showed that M-GGLG-liposomes were present for significantly longer at the injection site compared to GGLG-liposomes. The outstanding biological functions of the maleimide-modified liposomes as a novel drug delivery system make them ideally suited to a wide range of applications.
copMacclesfield
pubTaylor & Francis Ltd.
doi10.2147/IJN.S47749
urlhttp://search.proquest.com/docview/2223933388/
oafree_for_read
date2013-01-01